212
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Low-dose Decitabine Enhances Chidamide-Induced Apoptosis in Adult Acute Lymphoblast Leukemia, Especially for p16-Deleted Patients Through DNA Damage

, , , , , , , & show all
Pages 1259-1270 | Received 31 Mar 2017, Accepted 15 May 2017, Published online: 26 Jul 2017
 

Abstract

Aim: To investigate the combined action of decitabine (DAC) with chidamide (CS055) on acute lymphoblastic leukemia (ALL) cells. Materials & methods: ALL cell lines as well as primary cells from 17 ALL patients were subjected to different treatments and thereafter cell counting Kit-8 (CCK-8) assay, flow cytometry and western blot were employed to determine IC50, apoptosis and checkpoint kinase 1 and γH2A.X expression. Results: Low-dose DAC combined with CS055 could effectively kill ALL cells by the reduction of cell viability and induction of apoptosis. This was also observed in primary cells from 17 ALL patients, especially for those with p16 gene deletion. Suppression of checkpoint kinase 1 phosphorylation and upregulation of γH2A.X expression was demonstrated to participate in DAC plus CS055-induced apoptosis. Conclusion: Low-dose DAC could enhance chidamide-induced apoptosis in adult ALL, especially for patients with p16 gene deletion through DNA damage.

Financial & competing interests disclosure

This work is financially supported by Science and Technology Program of Guangzhou, China (201607010072), Medical Innovation Program of Fujian Province, PR China (2016-CXB-7) and Natural Science Foundation of Guangdong Province, China (2014A030313280). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Additional information

Funding

This work is financially supported by Science and Technology Program of Guangzhou, China (201607010072), Medical Innovation Program of Fujian Province, PR China (2016-CXB-7) and Natural Science Foundation of Guangdong Province, China (2014A030313280). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 99.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 303.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.